A phase III, double-blind, non-inferiority, randomized controlled trial of antiemetic prophylaxis for highly emetogenic chemotherapy without dexamethasone: CINV POD study

被引：0

作者：

Radhakrishnan, Venkatraman ^{[1
]}

Venkatakrishnan, Kritthivasan ^{[1
]}

Kalaiyarasi, Jayachandran Perumal ^{[1
]}

Selvarajan, Gangothri ^{[1
]}

Mahaboobasha, Nizamudin ^{[1
]}

Victor, Paulson Vijaykumar ^{[1
]}

Anbazhagan, Malarvizhi ^{[1
]}

Sivanandam, Deyva Manohari ^{[1
]}

Rajaraman, Swaminathan ^{[1
]}

机构：

[1] Canc Inst WIA, Chennai, India

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

12127

引用

页数：1

共 50 条

[11] ANTIEMETIC EFFICACY OF DEXAMETHASONE - A RANDOMIZED, DOUBLE-BLIND, CROSSOVER, PLACEBO CONTROLLED-STUDY
VANDELEUR, JJJPM
MULLER, NF
VANTURNHOUT, JM
PROGRESS IN CLINICAL PHARMACY: RATIONAL USE OF DRUGS, 1989, : 314 - 315
[12] Comparing recombinant human rabies monoclonal antibody (ormutivimab) with human rabies immunoglobulin (HRIG) for postexposure prophylaxis: A phase III, randomized, double-blind, non-inferiority trial
Liu, Xiaoqiang
Li, Yufeng
Li, Jingyu
Zhou, Jianmei
Guo, Jiangshu
Pu, Yi
Jiang, Ya
Zhou, Yaling
Jiang, Zhiwei
Shu, Qun
Wang, Cha
Wang, Jingke
Zhao, Yu
Zhao, Wei
Wang, Hui
Wei, Jingshuang
Yu, Hancheng
Gao, Jian
Li, Xiaona
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 134 : 53 - 62
[13] A phase II randomized, double-blind placebo-controlled trial of an antiemetic, 6-gingerol in solid tumor patients receiving moderately to highly emetogenic adjuvant chemotherapy.
Konmun, Jitprapa
Danwilai, Kwanjit
Ngamphaiboon, Nuttapong
Sookprasert, Aumkhae
Sirachainan, Ekaphop
Subongkot, Suphat
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[14] Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): A Randomized Double-Blind Non-Inferiority Trial
Lee, Yong-Seok
Bae, Hee-Joon
Kang, Dong-Wha
Lee, Seung-Hoon
Yu, Kyungho
Park, Jong-Moo
Cho, Yong-Jin
Hong, Keun-Sik
Kim, Dong-Eog
Kwon, Sun Uck
Lee, Kyung Bok
Rha, Joung-Ho
Koo, Jaseong
Han, Moon-Gu
Lee, Soo Joo
Lee, Ju-Hun
Jung, Sang Wook
Lee, Byung-Chul
Kim, Jong S.
CEREBROVASCULAR DISEASES, 2011, 32 (01) : 65 - 71
[15] INTRAVENOUS IMMUNOGLOBULIN OVERTREATMENT IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: A DOUBLE-BLIND, RANDOMIZED CONTROLLED NON-INFERIORITY TRIAL (IOC TRIAL)
Eftimov, F.
Adrichem, M. E.
de Haan, R. J.
Dijkgraaf, M. G. W.
Merkies, I. S. J.
Vrancken, A. F. J.
Notermans, N. C.
Faber, C. G.
van Doom, P. A.
van Schaik, I. N.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 135 - 135
[16] A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout
Zhang, Fengchun
Liu, Zhichun
Jiang, Lindi
Zhang, Hao
Zhao, Dongbao
Li, Yang
Zou, Hejian
Wang, Xiaoyue
Li, Xiangpei
Shi, Bingyin
Xu, Jianhua
Yang, Hongjie
Hu, Shaoxian
Qu, Shen
RHEUMATOLOGY AND THERAPY, 2019, 6 (04) : 543 - 557
[17] A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout
Fengchun Zhang
Zhichun Liu
Lindi Jiang
Hao Zhang
Dongbao Zhao
Yang Li
Hejian Zou
Xiaoyue Wang
Xiangpei Li
Bingyin Shi
Jianhua Xu
Hongjie Yang
Shaoxian Hu
Shen Qu
Rheumatology and Therapy, 2019, 6 : 543 - 557
[18] Cinnovex vs. Avonex: a double-blind, randomized, non-inferiority trial, preliminary results
Nafissi, Shahriar
Azimi, Amir Reza
Majidzadeh, Keivan
Mahboudi, Fereidoun
MULTIPLE SCLEROSIS, 2008, 14 : S168 - S168
[19] Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review
Turki A. Althunian
Anthonius de Boer
Olaf H. Klungel
Widya N. Insani
Rolf H. H. Groenwold
Trials, 18
[20] Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review
Althunian, Turki A.
de Boer, Anthonius
Klungel, Olaf H.
Insani, Widya N.
Groenwold, Rolf H. H.
TRIALS, 2017, 18

← 1 2 3 4 5 →